| | |
Three
Months Ended September 30, | | |
Nine
Months Ended September 30, | |
| | |
2024 | | |
2023 | | |
2024 | | |
2023 | |
| Net
revenue | |
$ | 115 | | |
$ | 429 | | |
$ | 395 | | |
$ | 1,189 | |
| | |
| | | |
| | | |
| | | |
| | |
| Cost
of revenues | |
| 43 | | |
| 159 | | |
| 184 | | |
| 593 | |
| Cost
of revenues – amortization of acquired intangibles | |
| 22 | | |
| 22 | | |
| 66 | | |
| 66 | |
| Gross
profit | |
| 50 | | |
| 248 | | |
| 145 | | |
| 530 | |
| | |
| | | |
| | | |
| | | |
| | |
| Operating
expenses: | |
| | | |
| | | |
| | | |
| | |
| Research
and development | |
| 2,817 | | |
| 2,185 | | |
| 7,582 | | |
| 6,747 | |
| Sales
and marketing | |
| 1,043 | | |
| 713 | | |
| 2,742 | | |
| 2,213 | |
| General
and administrative | |
| 2,565 | | |
| 2,487 | | |
| 7,645 | | |
| 9,430 | |
| Change
in fair value of contingent consideration | |
| 7,140 | | |
| (435 | ) | |
| 9,421 | | |
| (16,947 | ) |
| Impairment
losses | |
| — | | |
| 1,811 | | |
| — | | |
| 6,761 | |
| Impairment
loss on held for sale assets | |
| — | | |
| — | | |
| 169 | | |
| 1,283 | |
| Total
operating expenses | |
| 13,565 | | |
| 6,761 | | |
| 27,559 | | |
| 9,487 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss
from operations | |
| (13,515 | ) | |
| (6,513 | ) | |
| (27,414 | ) | |
| (8,957 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Other
(expenses) income: | |
| | | |
| | | |
| | | |
| | |
| Interest
expense | |
| (31 | ) | |
| (14 | ) | |
| (54 | ) | |
| (39 | ) |
| Unrealized
(loss) gain on marketable equity securities | |
| — | | |
| (89 | ) | |
| — | | |
| 8 | |
| Other
income, net | |
| 53 | | |
| 127 | | |
| 316 | | |
| 125 | |
| Total
other income, net | |
| 22 | | |
| 24 | | |
| 262 | | |
| 94 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss
from continuing operations | |
| (13,493 | ) | |
| (6,489 | ) | |
| (27,152 | ) | |
| (8,863 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Loss
from discontinued operations | |
| — | | |
| — | | |
| — | | |
| (2,926 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net
loss | |
$ | (13,493 | ) | |
$ | (6,489 | ) | |
$ | (27,152 | ) | |
$ | (11,789 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net
loss per share: | |
| | | |
| | | |
| | | |
| | |
| Net
loss from continuing operations - basic and diluted | |
$ | (13,493 | ) | |
$ | (6,687 | ) | |
$ | (27,415 | ) | |
$ | (9,602 | ) |
| Net
loss from discontinued operations - basic and diluted | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | (2,926 | ) |
| Net
loss attributable to common stockholders - basic and diluted | |
$ | (13,493 | ) | |
$ | (6,687 | ) | |
$ | (27,415 | ) | |
$ | (12,528 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net
loss from continuing operations per share - basic and diluted | |
$ | (0.98 | ) | |
$ | (0.81 | ) | |
$ | (2.36 | ) | |
$ | (1.29 | ) |
| Net
loss from discontinued operations per share - basic and diluted | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | (0.39 | ) |
| Net
loss attributable to common stockholders per share - basic and diluted | |
$ | (0.98 | ) | |
$ | (0.81 | ) | |
$ | (2.36 | ) | |
$ | (1.68 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Weighted
average shares outstanding - basic and diluted | |
| 13,714 | | |
| 8,256 | | |
| 11,624 | | |
| 7,446 | |
